8-K - ALX Oncology Holdings Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Other Event

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On January 30, 2026, ALX Oncology Holdings Inc. (the “Company”) entered into an underwriting agreement (the “Underwr

Material Agreement

$1.57$1.57$150.0M

8.01

Other Events. A copy of the press release announcing the pricing of the Offering is attached to this Current Report on Form 8-K as Exhibit 99.1. Forward-Looking

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated as of January 30, 2026, among ALX Oncology Holdings I

Exhibits Only

Source Document

Exhibits (5)

1.1

EX-1.1

4.1

EX-4.1

5.1

EX-5.1

8-K

99.1

EX-99.1